PeptideDB
de
EnglishEspañolDeutschPortuguês
PeptideKategorienVergleichLeitfädenGlossar

KLOW Protocol

Begrenzte Forschung

Four-Peptide Regenerative Blend

GewichtsverlustMetabolisch

KLOW builds upon GLOW protocol by adding KPV for enhanced anti-inflammatory action.

Molekulare und Forschungsdaten

Sequenz
GHK-Cu + TB-500 + BPC-157 + KPV (5:1:1:1 ratio)
Wege (Forschung)
injectable
Lagerung
Lyophilized: Room temperature. Reconstituted: 2-8°C, use within 4-6 weeks

Overview

KLOW builds upon GLOW protocol by adding KPV for enhanced anti-inflammatory action. This combination lacks clinical trials on the specific four-peptide formulation despite individual component research. Standard vial contains 80mg blend (50mg GHK-Cu, 10mg TB-500, 10mg BPC-157, 10mg KPV).

Mechanism of action

Each peptide contributes distinct biological pathways: GHK-Cu modulates gene expression for tissue repair, TB-500 enhances cellular migration and wound healing, BPC-157 upregulates growth factors for tissue regeneration, and KPV inhibits NF-κB inflammatory pathway.

Key research findings

  • Theoretical synergistic multi-pathway tissue repair
  • Anti-inflammatory effects across multiple mechanisms
  • Cellular regeneration support
  • Convenience of single injection dosing
  • KPV may reduce injection site reactions versus GLOW

Research applications

Primary Applications

  • Wound Healing — Multi-modal healing addressing tissue through complementary pathways
  • Post-Surgical Recovery — Enhanced tolerability with KPV versus GLOW formulation
  • Sports Injury Management — Single injection convenience factor
  • Skin Rejuvenation — Collagen stimulation and tissue regeneration

KLOW Protocol Häufig gestellte Fragen

How is KLOW different from the GLOW protocol?+

KLOW adds KPV to the GLOW formulation (GHK-Cu, TB-500, BPC-157). KPV provides additional anti-inflammatory benefits via NF-κB inhibition. The result is enhanced inflammation reduction with potentially fewer injection site reactions than GLOW alone. However, no clinical trials exist on this specific four-peptide combination.

Why do users get injection site reactions with KLOW?+

GHK-Cu, the primary component (50mg/80mg), is a copper peptide that can be irritating locally. Even with KPV's anti-inflammatory properties, some users experience redness and swelling at injection sites. Rotating sites and using lower doses help mitigate reactions.

Can I use KLOW for surgical recovery?+

Theoretically yes. The blend combines wound-healing (BPC-157, TB-500), anti-inflammatory (KPV, BPC-157), and tissue-regenerating (GHK-Cu) components. However, post-surgical use requires medical supervision due to effects on wound healing and clotting.

Is KLOW safe to use long-term?+

Unknown. No clinical studies exist on four-peptide protocols, and long-term effects are completely unknown. Most users cycle 4-6 weeks on with 2-4 weeks off to minimize theoretical risks while allowing benefits to develop.

References

  1. [1]Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene DataInternational Journal of Molecular Sciences
  2. [2]Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growthJournal of Orthopaedic Research
  3. [3]A first-in-human, randomized, double-blind, single- and multiple-dose, phase I study of recombinant human thymosin β4 in healthy Chinese volunteersJournal of Cellular and Molecular Medicine
  4. [4]PepT1-mediated tripeptide KPV uptake reduces intestinal inflammationGastroenterology
  5. [5]No Published Studies on KLOW CombinationN/A
  6. [6]Safety of Intravenous Infusion of BPC157 in Humans: A Pilot StudyAlternative Therapies in Health and Medicine
  7. [7]Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic ReviewHSS Journal
  8. [8]Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospectiveJournal of Peptide Science
  9. [9]KPV and RAPA Self-Assembled into Carrier-Free Nanodrugs for Vascular Calcification TherapyAdvanced Healthcare Materials

Verwandte Peptide

5-Amino-1MQ

Preclinical

NNMT Inhibitor | Longevity & Metabolic Enhancement

5-Amino-1MQ is a small molecule NNMT (nicotinamide N-methyltransferase) inhibitor that enhances cellular NAD+ levels and mitochondrial function.

LanglebigkeitMetabolischGewichtsverlust

AOD-9604

Well studied

Modified hGH Fragment | Fat Loss Peptide

AOD-9604 is a modified fragment of human growth hormone (amino acids 176-191) that stimulates lipolysis and inhibits lipogenesis without the side effects of full growth hormone.

GewichtsverlustMetabolisch

BAM-15

Moderate research

Mitochondrial Uncoupler | Metabolic Enhancer

BAM-15 is a synthetic mitochondrial uncoupler that has emerged as a promising research compound for obesity and metabolic disorders.

GewichtsverlustMetabolisch

Cagrilintide

Extensively studied

Long-Acting Amylin Receptor Agonist | Weight Loss & Diabetes

Novel long-acting lipidated amylin analog functioning as dual amylin and calcitonin receptor agonist for weight management and type 2 diabetes.

GewichtsverlustMetabolisch